Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 30, 2025 16:05 ET | Source: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals to Host a Conference Call to Discuss Updated Data from the Ongoing Phase 1b Trial of Tegoprubart in Kidney Transplantation Being Presented at the World Transplant Congress 2025

Eledon to Host a Conference Call to Discuss Updated Data from the Ongoing Phase 1b Trial of Tegoprubart in Kidney Transplantation Being Presented at WTC
June 25, 2025 16:01 ET | Source: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals to Host R&D Day on July 9, 2025 in New York City

Eledon Pharmaceuticals to Host R&D Day on July 9, 2025 in New York City
March 04, 2025 16:05 ET | Source: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals to Participate in Leerink Partners Global Healthcare Conference

Eledon Pharmaceuticals to Participate in Leerink Partners Global Healthcare Conference
January 29, 2025 16:05 ET | Source: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals to Participate in Guggenheim Securities SMID Cap Biotech Conference

Eledon Pharmaceuticals to Participate in Guggenheim SMID Cap Biotech Conference
November 12, 2024 16:01 ET | Source: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals Announces Recent Business Highlights and Third Quarter 2024 Financial Results

Eledon Pharmaceuticals Announces Recent Business Highlights and Third Quarter 2024 Financial Results
November 06, 2024 16:05 ET | Source: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals to Participate in Guggenheim Securities Inaugural Healthcare Innovation Conference

Eledon Pharmaceuticals to Participate in Guggenheim Securities Inaugural Healthcare Innovation Conference
October 29, 2024 07:46 ET | Source: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals Announces Pricing of $85 Million Underwritten Offering of Common Stock and Pre-Funded Warrants

Eledon Pharmaceuticals Announces Pricing of $85 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
September 11, 2024 16:05 ET | Source: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals to Present at the Cantor Global Healthcare Conference

Eledon Pharmaceuticals to Present at the Cantor Global Healthcare Conference
September 04, 2024 07:00 ET | Source: Eledon Pharmaceuticals, Inc.

Eledon Announces Completion of Enrollment in Phase 2 BESTOW Clinical Trial Assessing Tegoprubart for Prevention of Organ Rejection in Kidney Transplant Patients

Eledon Announces Completion of Enrollment in Phase 2 BESTOW Clinical Trial Assessing Tegoprubart for Prevention of Organ Rejection in Kidney Transplants
August 14, 2024 17:21 ET | Source: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals Reports Preliminary Second Quarter 2024 Operating Results

Eledon Pharmaceuticals Reports Preliminary Second Quarter 2024 Operating Results

Next Page keyboard_arrow_right